Detalhe da pesquisa
1.
Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cells.
Mol Ther
; 31(7): 2120-2131, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081789
2.
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8+ T cells.
Eur J Immunol
; 50(9): 1386-1399, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32383488
3.
The evolving landscape of immunotherapy in solid tumors.
J Surg Oncol
; 123(3): 798-806, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33595890
4.
Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma.
BMC Cancer
; 20(1): 229, 2020 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32183719
5.
Progressively Enhancing Stemness of Adoptively Transferred T Cells with PI3Kδ Blockade Improves Metabolism and Antitumor Immunity.
Cancer Res
; 84(1): 69-83, 2024 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801615
6.
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells.
bioRxiv
; 2023 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38187594
7.
The degree of T cell stemness differentially impacts the potency of adoptive cancer immunotherapy in a Lef-1 and Tcf-1 dependent manner.
bioRxiv
; 2023 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945574
8.
Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell- and CXCR3-dependent manner.
JCI Insight
; 8(8)2023 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881480
9.
Case Report: Delayed Onset Multi-Organ Toxicities in a Melanoma Patient Achieving Complete Response to BRAF/MEK Inhibition.
Front Oncol
; 12: 836845, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35433480
10.
Programmed death 1 (PD-1) and ligand (PD-L1) inhibitors in head and neck squamous cell carcinoma: A meta-analysis.
World J Otorhinolaryngol Head Neck Surg
; 8(3): 177-186, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36159902
11.
B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity.
J Immunother Cancer
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35017148
12.
Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy.
Front Immunol
; 12: 645242, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33815400
13.
Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies.
Oncoimmunology
; 10(1): 1959101, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34408920
14.
Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma.
Cell Rep Med
; 2(10): 100411, 2021 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34755131
15.
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma.
Cell Rep Med
; 2(10): 100426, 2021 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34755137
16.
Impact of PD-L1 expression and human papillomavirus status in anti-PD1/PDL1 immunotherapy for head and neck squamous cell carcinoma-Systematic review and meta-analysis.
Head Neck
; 42(4): 774-786, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31762164
17.
The Evolution of Care of Cancers of the Head and Neck Region: State of the Science in 2020.
Cancers (Basel)
; 12(6)2020 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32545409
18.
IL6 Fuels Durable Memory for Th17 Cell-Mediated Responses to Tumors.
Cancer Res
; 80(18): 3920-3932, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561531
19.
Identification of human CD4+ T cell populations with distinct antitumor activity.
Sci Adv
; 6(27)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32937437
20.
Immune Evasion by Head and Neck Cancer: Foundations for Combination Therapy.
Trends Cancer
; 5(4): 208-232, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30961829